1 |
Siegel R, Miller K, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
|
2 |
Luo YH, Chiu CH, Kuo CHS, et al. Lung cancer in republic of China[J]. J Thorac Oncol, 2021, 16(4): 519-27.
|
3 |
Butt G, Romero MA, Tahir F, et al. Emerging themes of regulation of oncogenic proteins by Solanum nigrum and its bioactive molecules in different cancers[J]. J Cell Biochem, 2018, 119(12): 9640-4.
|
4 |
Jagadeeshan S, David D, Jisha S, et al. Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway[J]. BMC Complement Altern Med, 2017, 17(1): 370.
|
5 |
Wang X, Zou S, Lan YL, et al. Solasonine inhibits glioma growth through anti-inflammatory pathways[J]. Am J Transl Res, 2017, 9(9): 3977-89.
|
6 |
闫 霞, 郑佳露, 沈克平, 等. 龙葵抗肿瘤作用及机制研究[J]. 世界中西医结合杂志, 2017, 12(8): 1177-80.
|
7 |
吴建博. 龙葵碱通过诱导microRNA-138表达促进食管癌细胞对5-FU/DDP的药物敏感性[D]. 郑州: 郑州大学, 2019.
|
8 |
张福瑞. 龙葵碱增强肺腺癌细胞对顺铂和X射线敏感性及其机制研究[D]. 郑州: 郑州大学, 2016.
|
9 |
Yang J, Huang WJ, Tan WF. Solasonine, A natural glycoalkaloid compound, inhibits gli-mediated transcriptional activity[J]. Molecules, 2016, 21(10): 1364.
|
10 |
Pham MQ, Tran THV, Pham QL, et al. In silico analysis of the binding properties of solasonine to mortalin and p53, and in vitro pharmacological studies of its apoptotic and cytotoxic effects on human HepG2 and Hep3b hepatocellular carcinoma cells[J]. Fundam Clin Pharmacol, 2019, 33(4): 385-96.
|
11 |
Liu Z, Ma CJ, Tang XJ, et al. The reciprocal interaction between LncRNA CCAT1 and miR-375-3p contribute to the downregulation of IRF5 gene expression by solasonine in HepG2 human hepatocellular carcinoma cells[J]. Front Oncol, 2019, 9: 1081.
|
12 |
Zhong YB, Li SS, Chen LL, et al. In vivo toxicity of solasonine and its effects on cyp450 family gene expression in the livers of male mice from four strains[J]. Toxins, 2018, 10(12): 487.
|
13 |
李龙妹, 黄锦鹏, 河文峰, 等. 龙葵提取物澳洲茄碱诱导A549细胞凋亡的机制研究[J]. 中药新药与临床药理, 2020, 31(12): 1422-7.
|
14 |
Zeng YY, Luo YB, Ju XD, et al. Solasonine causes redox imbalance and mitochondrial oxidative stress of ferroptosis in lung adenocarcinoma[J]. Front Oncol, 2022, 12: 874900.
|
15 |
Zhang L, Li YD, Wang QC, et al. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer[J]. Mol Cancer, 2020, 19(1): 10.
|
16 |
Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations[J]. Annu Rev Med, 2020, 71: 103-16.
|
17 |
Álvarez-Garcia V, Tawil Y, Wise HM, et al. Mechanisms of PTEN loss in cancer: it's all about diversity[J]. Semin Cancer Biol, 2019, 59: 66-79.
|
18 |
Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins[J]. Nat Rev Mol Cell Biol, 2019, 20(3): 175-93.
|
19 |
Warren CFA, Wong-Brown MW, Bowden NA. BCL-2 family isoforms in apoptosis and cancer[J]. Cell Death Dis, 2019, 10(3): 177.
|
20 |
Yang DL, He LJ, Ma SQ, et al. Pharmacological targeting of bcl-2 induces caspase 3-mediated cleavage of HDAC6 and regulates the autophagy process in colorectal cancer[J]. Int J Mol Sci, 2023, 24(7): 6662.
|
21 |
Gur C, Kandemir FM, Caglayan C, et al. Chemopreventive effects of hesperidin against paclitaxel-induced hepatotoxicity and nephrotoxicity via amendment of Nrf2/HO-1 and caspase-3/Bax/Bcl-2 signaling pathways[J]. Chem Biol Interact, 2022, 365: 110073.
|
22 |
Liu T, Zhang BK, Gao YT, et al. Identification of ACHE as the hub gene targeting solasonine associated with non-small cell lung cancer (NSCLC) using integrated bioinformatics analysis[J]. PeerJ, 2023, 11: e16195.
|
23 |
Akbari-Birgani S, Khademy M, Mohseni-Dargah M, et al. Caspases interplay with kinases and phosphatases to determine cell fate[J]. Eur J Pharmacol, 2019, 855: 20-9.
|
24 |
Cheng YJ, Lee CH, Lin YP, et al. Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway[J]. Int J Cancer, 2008, 123(6): 1278-85.
|
25 |
Delbridge AR, Strasser A. The BCL-2 protein family, BH3-mimetics and cancer therapy[J]. Cell Death Differ, 2015, 22(7): 1071-80.
|
26 |
Chen SC, Bie MJ, Wang XW, et al. PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling[J]. Genes Dis, 2022, 9(6): 1650-61.
|
27 |
Liu Y, Zhang TQ, Deng J, et al. The cytotoxicity of γδT cells in non-small cell lung cancer mediated via coordination of the BCL-2 and AKT pathways[J]. Oncogene, 2023, 42(49): 3648-54.
|
28 |
Bo S, Lai J, Lin H, et al. Purpurin, a anthraquinone induces ROS-mediated A549 lung cancer cell apoptosis via inhibition of PI3K/AKT and proliferation[J]. J Pharm Pharmacol, 2021, 73(8): 1101-8.
|
29 |
Zhou Y, Bai L, Tian L, et al. Iridium(III)-BBIP complexes induce apoptosis via PI3K/AKT/mTOR pathway and inhibit A549 lung tumor growth in vivo [J]. J Inorg Biochem, 2021, 223: 111550.
|